Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huber Engineered Materials (HEM) is a global leader in the development of specialty chemical ingredients, focusing on engineered minerals and silica-based technologies. Within the life sciences and healthcare sectors, the company is a major supplier of high-purity calcium carbonate and specialty silica used as excipients in pharmaceutical and nutraceutical applications. Their products, including the Zeopharm and Hubercarb brands, serve as critical binders, disintegrants, and carriers for solid dosage forms and oral care products. As a division of the J.M. Huber Corporation, HEM leverages extensive material science expertise to provide customized solutions for drug delivery and nutritional fortification. The company maintains a global manufacturing footprint with facilities that adhere to stringent quality standards, including GMP for pharmaceutical-grade ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huber Engineering Materials.